T 0391/07 (Immunotherapy of cancer/UNIVERSITY OF PENNSYLVANIA) of 13.01.2009
- European Case Law Identifier
- ECLI:EP:BA:2009:T039107.20090113
- Date of decision
- 13 January 2009
- Case number
- T 0391/07
- Petition for review of
- -
- Application number
- 95939926.2
- IPC class
- A61K 39/02
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
- Applicant name
- The Trustees of The University of Pennsylvania
- Opponent name
- Anza Therapeutics, Inc.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention R 139
- Keywords
- Main request; added subject-matter (no); inventive step (yes)
- Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent in amended form on the basis of the following documents:
o claims 1 to 8 of the main request filed at the oral proceedings;
o pages 2 to 9 of the amended description, filed at the oral proceedings;
o figures 1 to 8 of the patent specification.